According to Trinity Biotech 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.21765. At the end of 2023 the company had a P/S ratio of 0.4571.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.4571 | -21.44% |
2022 | 0.5819 | 80.99% |
2021 | 0.3215 | -58.83% |
2020 | 0.7809 | 226.95% |
2019 | 0.2388 | -51.58% |
2018 | 0.4933 | -54.18% |
2017 | 1.08 | -32.92% |
2016 | 1.61 | -42.93% |
2015 | 2.81 | -28.56% |
2014 | 3.94 | -38.56% |
2013 | 6.41 | 63.51% |
2012 | 3.92 | 41.29% |
2011 | 2.77 | 33.09% |
2010 | 2.08 | 210.58% |
2009 | 0.6710 | 216.41% |
2008 | 0.2121 | -82.03% |
2007 | 1.18 | -12.04% |
2006 | 1.34 | 6.54% |
2005 | 1.26 | 144.61% |
2004 | 0.5147 | -47.16% |
2003 | 0.9741 | 272% |
2002 | 0.2619 | -35.69% |
2001 | 0.4072 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | 4.60 | 2,012.69% | ๐บ๐ธ USA |
Thermo Fisher Scientific TMO | 5.12 | 2,252.98% | ๐บ๐ธ USA |
Danaher DHR | 8.12 | 3,631.05% | ๐บ๐ธ USA |
QuidelOrtho QDEL | 0.8852 | 306.72% | ๐บ๐ธ USA |
OraSure Technologies OSUR | 1.01 | 362.09% | ๐บ๐ธ USA |
Chembio Diagnostics CEMI | 0.3457 | 58.83% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | 2.95 | 1,253.35% | ๐บ๐ธ USA |